home > ebr > autumn 2009 > mycoplasma contamination - the invisible threat?


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


News and Press Releases

FUJIFILM Diosynth Biotechnologies Breaks Ground on Large-Scale Microbial Manufacturing Facility Expansion in Billingham, UK

BILLINGHAM, UNITED KINGDOM, September 22, 2022 FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced today the start of the expansion of its large-scale microbial manufacturing facility located at the Billingham, UK campus. The company held a small internal ceremony at the site on 6 September 2022.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement